Filter Results:
(991)
Show Results For
- All HBS Web
(991)
- People (4)
- News (256)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (397)
Show Results For
- All HBS Web
(991)
- People (4)
- News (256)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (397)
- 02 Apr 2014
- News
Disrupting the Criminal Supply Chain
her dual law and business degrees to fight some of the world's most disturbing criminals. Since 2011, Brochu, 42, has been the United Nations Office on Drugs and Crime's Expert on Child Exploitation and Human Trafficking, a position she... View Details
- 24 Mar 2020
- Research & Ideas
These Coronavirus Heroes Show Us How Crisis Leadership Works
American manufacturer of antibiotics—those life-saving drugs required for pneumonia caused by COVID-19—as others have abandoned them to pursue more lucrative drugs. Frazier elected to stay in the business because he knows how essential... View Details
- 01 Mar 2015
- News
In My Humble Opinion: Leonard Dick (MBA 1990)
it’s not drug problems or throwing a stapler at the assistant. It’s missing a delivery date. A veteran I worked with told me, ‘Your job isn’t to make it great; your job is to get it in by Tuesday.’ ” Dick’s prime-time résumé includes The... View Details
- Web
1.18 Field Global Capstone | MBA
choice of location(s) for coursework participation, whichever is the least-restrictive reasonable alternative. Drug & Alcohol Policy The HBS Drug & Alcohol Policy states expectations for responsible alcohol... View Details
- 18 Nov 2014
- First Look
First Look: November 18
innovative drug candidates for testing in patients. Project teams consisted of Pfizer scientists and academics working side-by-side to reduce the time needed to bring a therapeutic drug from the lab to a... View Details
Keywords: Sean Silverthorne
- 02 Sep 2008
- First Look
First Look: September 3, 2008
Note on Generic Drugs in the European Union Harvard Business School Note 309-019 Rules governing the introduction of generic drugs in U.S. and EU have some similarities but significant differences because of... View Details
Keywords: Sean Silverthorne
- 15 Feb 2012
- Op-Ed
Occupy Wall Street Protestors Have a Point
unaffordable (which the pharmaceutical company Cipla did with HIV/AIDS drugs in Africa), and that brought housing to urban poor (one of building materials maker CEMEX's accomplishments in Mexico). Based on our research, we believe the... View Details
- 28 May 2014
- Research & Ideas
Building Histories of Emerging Economies One Interview at a Time
you are saving lives. So it has to have a humanitarian angle to it." (Cipla manufactures generic versions of a number of commonly prescribed medicines and is the world's largest manufacturer of the antiretroviral drugs that fight HIV and... View Details
Keywords: by Julia Hanna
- 08 Aug 2011
- Research & Ideas
The Death of the Global Manager
and its efforts to establish Humanitarian Assistance for Neglected Diseases (HAND), a corporate social responsibility program focused on treatments for diseases that typically affect too small a population to warrant the attention of drug... View Details
Keywords: by Julia Hanna
- 03 Apr 2019
- News
Finding Common Ground
shelters, Shumway talked to homeless residents about their circumstances. “These are good people,” he says. “They may have started to self-medicate with drugs or alcohol because they didn’t have access to the psychiatric or medical... View Details
Keywords: Deborah Blagg
- 03 Apr 2007
- First Look
First Look: April 3, 2007
drug discovery organization at Wyeth Pharmaceuticals and focuses on the decisions to: (1) centralize decision-making within drug discovery and (2) institute numerical metrics—jointly affecting all R&D... View Details
Keywords: Martha Lagace
- 01 Jun 2010
- News
$how Me the Money
Bank made a $160 million settlement with the Justice Department, agreeing it had been lax about accepting drug money from Mexico.) While U.S. law is tough on drug trafficking, terrorist financing, bank... View Details
- 07 Aug 2006
- Research & Ideas
Whatever Happened to Caveat Emptor?
basic material needs to concerns about the safety and quality of these products. When products did fail—as happened dramatically in the late 1950s with the antinausea drug Thalidomide—such cases became the focus of aggressive consumer... View Details
- 19 Aug 2024
- News
Quantum Leap
Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Dan Morrell: Hi, this is Dan Morrell, host of Skydeck. Quantum computing has long been talked about as one of the next big things—the kind of technology, like AI, that will change everything. But to our... View Details
- 01 Mar 2012
- News
Capitalism’s New Agenda
hundreds of millions of rural poor into the market system (as China Mobile did by bringing mobile phone service to the Chinese countryside), that brought medicine where it had been unaffordable (which the Indian pharmaceutical firm Cipla did with HIV/AIDS View Details
- 25 Jun 2020
- News
Covering All Corners
is coordinating with Gilead Sciences, maker of Remdesivir, to distribute and manufacture the antiviral drug treatment for use in 127 countries, including Egypt. It was recently approved for emergency use by the United States, India,... View Details
- 26 Jun 2000
- Research & Ideas
What’s an Internet Business Model? Ask a Health Care Professional
process of testing drugs and bringing them to market. No matter how ingenious a business model may appear, however, all panelists agreed that the trust of patients remains paramount. Patient trust, then, could well emerge as the ultimate... View Details
- 28 Mar 2023
- Blog Post
Novo Nordisk
delivery system used to treat patients with Type II diabetes (not all of insulin’s use cases). It currently needs 100-175x the amount of active pharmaceutical ingredient (API) compared to insulin injection pens because the oral drug is... View Details
- 20 Nov 2006
- Research & Ideas
Open Source Science: A New Model for Innovation
problems that were posted? A: Innovations happen at the intersection of disciplines. People have talked about that a lot and I think we're providing some systematic evidence now with this study. Another example is that a pharmaceutical company got unusual toxicology... View Details
Keywords: by Martha Lagace
- 23 Jan 2019
- News
The Promise of Personalized Medicine
and a 501(c)(3) called Cure Rare Disease. With the foundation, Horgan is trying to build something radical: A model for personalizing drug development, with the hopes of saving not only his brother but countless others. READ MORE Morrell:... View Details